Neal Rosen

Neal Rosen

Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4441032
person_outline Neal Rosen's MOST POPULAR ARTICLES
1-) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktKE O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Reilly, F Rojo, QB She, D Solit, GB Mills, D Smith, H Lane, ...Cancer research 66 (3), 1500-1508, 200628412006
2-) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFPI Poulikakos, C Zhang, G Bollag, KM Shokat, N RosenNature 464 (7287), 427-430, 201018412010
3-) Crystal structure of an Hsp90–geldanamycin complex: targeting of a protein chaperone by an antitumor agentCE Stebbins, AA Russo, C Schneider, N Rosen, FU Hartl, NP PavletichCell 89 (2), 239-250, 199716691997
4-) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E)PI Poulikakos, Y Persaud, M Janakiraman, X Kong, C Ng, G Moriceau, ...Nature 480 (7377), 387-390, 201116742011
5-) BRAF mutation predicts sensitivity to MEK inhibitionDB Solit, LA Garraway, CA Pratilas, A Sawai, G Getz, A Basso, Q Ye, ...Nature 439 (7074), 358-362, 200615502006